Utility of femorofemoral bypass. Comparison of results with indications for operation

S B Self1, J D Richardson, T W Klamer

  • 1Department of Surgery, University of Louisville School of Medicine, Kentucky 40292.

The American Surgeon
|September 1, 1991
PubMed

Insights

Femorofemoral bypass (FFB) is effective for limb salvage in acute ischemia or failed vascular prostheses. However, its use as a primary procedure in good-risk patients is not supported due to limited patency rates.

Area of Science:

  • Vascular Surgery
  • Cardiovascular Medicine

Background:

  • Femorofemoral bypass (FFB) is a surgical procedure used to treat peripheral artery disease.
  • Indications for FFB include acute limb ischemia, chronic ischemia after failed aortic reconstruction, and as an alternative for high-risk patients.

Purpose of the Study:

  • To evaluate the outcomes of femorofemoral bypass (FFB) in a diverse patient population.
  • To assess the efficacy of FFB in terms of graft patency, limb salvage, and operative mortality.

Main Methods:

  • Retrospective analysis of 68 patients who underwent femorofemoral bypass (FFB) between 1980 and 1989.
  • Patients were categorized based on the indication for surgery: acute ischemia, chronic ischemia post-aortic reconstruction, elective FFB in good-risk patients, and FFB in poor-risk patients.

Main Results:

  • Infectious complications were significant in patients operated on for acute ischemia, contributing to graft failure.
  • The 5-year primary patency rate was 42%, with similar rates across all patient groups.
  • Overall operative mortality was 4.4%, and limb salvage rates were 75%.

Conclusions:

  • Femorofemoral bypass (FFB) is a viable option for limb salvage in patients with acute ischemia or those with a failed vascular prosthesis.
  • FFB can provide adequate inflow for poor-risk patients unsuitable for aortic reconstruction.
  • The patency rates do not support the use of FFB as a primary procedure of choice in good-risk patients.